|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.7 TWD | -0.39% |
|
+0.40% | -13.04% |
Li Kang Biomedical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 629.38 million compared to TWD 684.25 million a year ago. Net income was TWD 110.99 million compared to TWD 112.09 million a year ago.
Basic earnings per share from continuing operations was TWD 4.14 compared to TWD 4.18 a year ago. Diluted earnings per share from continuing operations was TWD 4.12 compared to TWD 4.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.04% | 49.93M | |
| +15.92% | 8.35B | |
| +3.37% | 7.62B | |
| +1.49% | 6.01B | |
| -5.33% | 3.75B | |
| -7.57% | 3.7B | |
| -2.94% | 1.34B | |
| -26.08% | 1.13B | |
| +14.95% | 992M | |
| -9.40% | 925M |
LI KANG BIOMEDICAL CO., LTD. 
